This brand name is authorized in Germany, Japan
The drug SPIROPENT contains one active pharmaceutical ingredient (API):
|
1
Clenbuterol
UNII GOR5747GWU - CLENBUTEROL HYDROCHLORIDE
|
|
Clenbuterol is a direct-acting β2 sympathomimetic agent for the treatment of chronic obstructive airway diseases. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03CC13 | Clenbuterol | R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CC Selective beta-2-adrenoreceptor agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 01980325 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2259006F1080 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
